Twist Bioscience (TWST) News Today $44.25 -0.69 (-1.54%) Closing price 04:00 PM EasternExtended Trading$41.02 -3.23 (-7.29%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Twist Bioscience Co. (NASDAQ:TWST) SVP Paula Green Sells 291 SharesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 291 shares of Twist Bioscience stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $41.68, for a total value of $12,128.88. Following the sale, the senior vice president now owns 130,621 shares of the company's stock, valued at approximately $5,444,283.28. This trade represents a 0.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.March 25 at 4:32 PM | marketbeat.comEmily M. Leproust Sells 1,726 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 1,726 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $41.68, for a total value of $71,939.68. Following the sale, the chief executive officer now directly owns 660,966 shares in the company, valued at approximately $27,549,062.88. The trade was a 0.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.March 25 at 4:32 PM | marketbeat.comFox Run Management L.L.C. Has $778,000 Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Fox Run Management L.L.C. grew its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 57.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,739 shares of the company's stock aMarch 25 at 5:27 AM | marketbeat.comMagnetar Financial LLC Makes New Investment in Twist Bioscience Co. (NASDAQ:TWST)Magnetar Financial LLC bought a new stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 7,246 shares of the company's stock, valued at approximately $337,000. Several other large invesMarch 24 at 4:42 AM | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have earned an average rating of "Moderate Buy" from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold ratMarch 24 at 4:20 AM | marketbeat.comProficio Capital Partners LLC Buys Shares of 30,717 Twist Bioscience Co. (NASDAQ:TWST)Proficio Capital Partners LLC bought a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 30,717 shares of the company's stock, valued at approximately $1,427,000. Proficio Capital Partners LLC owneMarch 21, 2025 | marketbeat.comTwist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to BuyMarch 20, 2025 | msn.comTwist Bioscience Co. (NASDAQ:TWST) Shares Acquired by Thrivent Financial for LutheransThrivent Financial for Lutherans grew its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 54.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,505,753 shares of the company's stock afterMarch 20, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. increased its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 542,832 shares of the company's stockMarch 19, 2025 | marketbeat.comNikko Asset Management Americas Inc. Reduces Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Nikko Asset Management Americas Inc. reduced its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,612,964 shares of the company's stock after sellingMarch 18, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by William Blair Investment Management LLCWilliam Blair Investment Management LLC cut its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 15.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,949,723 shares of the company'sMarch 18, 2025 | marketbeat.comAlphaQuest LLC Buys 7,818 Shares of Twist Bioscience Co. (NASDAQ:TWST)AlphaQuest LLC raised its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 216.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,422 shares of the company's stock after acquiring an additional 7,818 shares during the perMarch 13, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Trading Up 10.3% - Time to Buy?Twist Bioscience (NASDAQ:TWST) Trading Up 10.3% - Here's WhyMarch 12, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST)Victory Capital Management Inc. boosted its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 12.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 372,291 shares of the company's stock after acquiring an additional 40,482 shareMarch 12, 2025 | marketbeat.comDennis Cho Sells 277 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 277 shares of the firm's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $40.91, for a total value of $11,332.07. Following the completion of the transaction, the insider now directly owns 111,984 shares in the company, valued at $4,581,265.44. The trade was a 0.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.March 11, 2025 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) SVP Sells 918 Shares of StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 918 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $40.91, for a total value of $37,555.38. Following the completion of the sale, the senior vice president now owns 130,912 shares in the company, valued at $5,355,609.92. This represents a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.March 11, 2025 | marketbeat.comEmily M. Leproust Sells 2,402 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 2,402 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $40.91, for a total transaction of $98,265.82. Following the transaction, the chief executive officer now directly owns 662,692 shares of the company's stock, valued at $27,110,729.72. This represents a 0.36 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.March 11, 2025 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) Insider Sells 277 Shares of StockMarch 11, 2025 | insidertrades.comBank of New York Mellon Corp Decreases Position in Twist Bioscience Co. (NASDAQ:TWST)Bank of New York Mellon Corp lessened its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 5.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 579,576 shares of the company's stock after selling 35,373 sharesMarch 9, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Trading Down 5.6% - Here's What HappenedTwist Bioscience (NASDAQ:TWST) Trading Down 5.6% - What's Next?March 8, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Buys 40,189 Shares of Twist Bioscience Co. (NASDAQ:TWST)Vestmark Advisory Solutions Inc. lifted its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 64.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 102,928 shares of the comMarch 7, 2025 | marketbeat.comProficio Capital Partners LLC Takes $1.43 Million Position in Twist Bioscience Co. (NASDAQ:TWST)Proficio Capital Partners LLC purchased a new stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 30,717 shares of the company's stock, valued at approximately $1,March 7, 2025 | marketbeat.comTwist Bioscience is Now Oversold (TWST)March 6, 2025 | nasdaq.comTD Cowen Sticks to Their Buy Rating for Twist Bioscience (TWST)March 6, 2025 | markets.businessinsider.comIs Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now?March 1, 2025 | finance.yahoo.comHandelsbanken Fonder AB Purchases New Position in Twist Bioscience Co. (NASDAQ:TWST)Handelsbanken Fonder AB purchased a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 18,400 shares of the company's stock, valued at approximately $855,000. Several other instituMarch 1, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has givFebruary 27, 2025 | marketbeat.comARK Investment Management LLC Acquires 237,772 Shares of Twist Bioscience Co. (NASDAQ:TWST)ARK Investment Management LLC increased its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,595,865 shares of the company's stock after acquiring an aFebruary 26, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Principal Financial Group Inc.Principal Financial Group Inc. lifted its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 81.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 374,551 shares of the coFebruary 26, 2025 | marketbeat.comTwist Bioscience to Present at Upcoming Investor ConferencesFebruary 25, 2025 | businesswire.comIeq Capital LLC Has $2.88 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST)Ieq Capital LLC raised its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 21.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,034 shares of the company's stock after acquiring an additionalFebruary 23, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund reduced its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 441,989 shares of the companyFebruary 23, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST)State of New Jersey Common Pension Fund D grew its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,803 shares of the company's stock aFebruary 21, 2025 | marketbeat.comBaillie Gifford & Co. Sells 56,802 Shares of Twist Bioscience Co. (NASDAQ:TWST)Baillie Gifford & Co. lowered its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 6.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 777,537 shares of the company's stock after selling 56,802 shareFebruary 18, 2025 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) Director Sells 2,940 Shares of StockFebruary 12, 2025 | insidertrades.comTwist Bioscience director Robert Chess sells shares totaling $156,216February 11, 2025 | msn.comTwist Bioscience approves stock increase, officer exculpationFebruary 11, 2025 | msn.comTwist Bioscience Co. (NASDAQ:TWST) Director Robert Chess Sells 2,940 SharesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) Director Robert Chess sold 2,940 shares of the company's stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $53.13, for a total transaction of $156,202.20. Following the transaction, the director now directly owns 18,173 shares of the company's stock, valued at approximately $965,531.49. This represents a 13.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.February 11, 2025 | marketbeat.comCathie Wood’s ARK Investment bought 268K shares of Twist Bioscience todayFebruary 11, 2025 | markets.businessinsider.comTwist Bioscience (NASDAQ:TWST) Shares Down 5.8% - Should You Sell?Twist Bioscience (NASDAQ:TWST) Shares Down 5.8% - Here's What HappenedFebruary 10, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 248,702 Shares of Twist Bioscience Co. (NASDAQ:TWST)Sumitomo Mitsui Trust Group Inc. lowered its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,612,964 shares of the company's stock after seFebruary 9, 2025 | marketbeat.comEarnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsFebruary 8, 2025 | uk.finance.yahoo.comTwist Bioscience Corporation (TWST): Among Cathie Wood’s Top Stock Picks for 2025February 7, 2025 | msn.comLeerink Partnrs Analysts Boost Earnings Estimates for TWSTTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Stock analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for Twist Bioscience in a research report issued to clients and investors on Monday, February 3rd. Leerink Partnrs analyst P. Souda now anticipates that the compFebruary 6, 2025 | marketbeat.comWilliam Blair Analysts Increase Earnings Estimates for TWSTTwist Bioscience Co. (NASDAQ:TWST - Free Report) - William Blair increased their Q2 2025 earnings estimates for shares of Twist Bioscience in a report released on Tuesday, February 4th. William Blair analyst M. Larew now anticipates that the company will post earnings of ($0.55) per share for theFebruary 6, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Dennis Cho Sells 806 SharesFebruary 6, 2025 | insidertrades.comTwist Bioscience: Valuation Is Weighing On The StockFebruary 6, 2025 | seekingalpha.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) Insider Sells 806 Shares of StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 806 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $49.35, for a total transaction of $39,776.10. Following the completion of the transaction, the insider now owns 112,221 shares of the company's stock, valued at approximately $5,538,106.35. This trade represents a 0.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.February 5, 2025 | marketbeat.comPaula Green Sells 1,259 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 1,259 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $49.35, for a total value of $62,131.65. Following the sale, the senior vice president now owns 132,014 shares of the company's stock, valued at approximately $6,514,890.90. The trade was a 0.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.February 5, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $140,400.75 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 2,845 shares of Twist Bioscience stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $49.35, for a total transaction of $140,400.75. Following the completion of the transaction, the chief operating officer now directly owns 269,199 shares of the company's stock, valued at $13,284,970.65. This trade represents a 1.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.February 5, 2025 | marketbeat.com Remove Ads Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Media Mentions By Week TWST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼0.750.62▲Average Medical News Sentiment TWST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼136▲TWST Articles Average Week Remove Ads Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ascendis Pharma A/S News Vaxcyte News Qiagen News Roivant Sciences News Sarepta Therapeutics News Revolution Medicines News BridgeBio Pharma News Lantheus News TG Therapeutics News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TWST Stock Free TWST Stock Alerts